Trial Details

Not Recruiting
Basic Information
Clinical ID c3258
Identifier JPRN-UMIN000004242
Trial Title Leukocytapheresis for Maintenance of Remission in Patients with Refractory Inflammatory Bowel Disease: A single-centre, Randomized, Double Blinded Trial - Leukocytapheresis as Maintenance of Remission in Patients with Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions Ulcerative Colitis
Interventions The patients assigned to the True arm, each receives one Adacolumn GMA session every 4 weeks for up to 48 weeks. The circuit line was covered securely by a curtain to blind both the physician and the patients on the type of treatment. The patients assigned to the sham arm, each receives one extracorporeal procedure with the circuit blood lines without the Adacolumn every 4 weeks for up to 48 weeks. The circuit line was covered securely by a curtain to blind both the physician and the patients on the type of treatment. The patients assigned to the control arm, each receives conventional medications without any extracorporeal circulation.
Participant Information
Sponsor Department of Lower Gastroenterology, Hyogo College of Medicine
City -
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement INFANT
Study Design
Study Type Interventional
Phase PHASE2
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date 2009-12-01